Next Article in Journal
Neural Underpinnings of Obesity: The Role of Oxidative Stress and Inflammation in the Brain
Next Article in Special Issue
Antioxidants in Plants: A Valorization Potential Emphasizing the Need for the Conservation of Plant Biodiversity in Cuba
Previous Article in Journal
Changes in Bioactive Compounds, Antioxidant Activity, and Nutritional Quality of Blood Orange Cultivars at Different Storage Temperatures
Previous Article in Special Issue
Antitumoral Drug Potential of Tryptophan-Betaxanthin and Related Plant Betalains in the Caenorhabditis elegans Tumoral Model
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antioxidants
Volume 9
Issue 10
10.3390/antiox9101017
antioxidants-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Anthocyanins from Purple Tomatoes as Novel Antioxidants to Promote Human Health

by
Silvia Gonzali
and
Pierdomenico Perata
*
PlantLab, Institute of Life Sciences, Scuola Superiore Sant’Anna, 56127 Pisa, Italy
*
Author to whom correspondence should be addressed.
Antioxidants 2020, 9(10), 1017; https://doi.org/10.3390/antiox9101017
Submission received: 29 September 2020 / Revised: 15 October 2020 / Accepted: 16 October 2020 / Published: 20 October 2020
(This article belongs to the Special Issue Plant Antioxidants in the “One Health” Paradigm)
Browse Figures
Versions Notes

Abstract

:
Anthocyanins are plant secondary metabolites belonging to the class of polyphenols, whose beneficial roles in the prevention and treatment of several important human diseases have been demonstrated in many epidemiological studies. Their intake through diet strictly depends on the eating habits, as anthocyanins are contained in red and purple fruit and vegetables as well as in some processed foods and beverages, such as red wine. Genetic engineering and breeding programs have been recently carried out to increase the content of anthocyanins in candidate plant species which cannot offer satisfactory levels of these precious compounds. Tomato (Solanum lycopersicum) is a vegetable commodity where these strategies have resulted in success, leading to the production of new anthocyanin-rich fruit varieties, some of which are already marketed. These varieties produce purple fruits with a high nutraceutical value, combining the health benefits of the anthocyanins to the other classical tomato phytochemicals, particularly carotenoids. The antioxidant capacity in tomato purple fruits is higher than in non-anthocyanin tomatoes and their healthy role has already been demonstrated in both in vitro and in vivo studies. Recent evidence has indicated a particular capacity of tomato fruit anthocyanins to act as scavengers of harmful reactive chemical species and inhibitors of proliferating cancer cells, as well as anti-inflammatory molecules.

1. Anthocyanins as Beneficial Plant Metabolites

Many phytochemicals have long been recognized as health beneficial compounds and have been used in traditional medicines for thousands of years. Among them, plant-derived polyphenols are increasingly attracting research interest due to their positive effects in terms of disease prevention and treatment. Anthocyanins belong to this group of metabolites. They represent a water-soluble subclass of flavonoids, responsible for red, purple and blue colorations of flowers, fruits and leaves in many species. Their functions in plants are different—as coloured pigments, they attract pollinators and seed dispersers in reproductive organs; as antioxidant compounds, they play a pivotal role in counteracting various types of stress, such as excessive light, in vegetative organs. As a consequence, their content can be strongly affected by environmental factors, such as light and temperature, as well as by biotic and abiotic stress conditions [1].
Anthocyanins are the glycosylated derivatives of the anthocyanidin molecules, whose chemical structure is based on a C15 skeleton formed by two polyhydroxylated or polymethoxylated aromatic rings (A and B) linked by a C3 benzene ring (C) (Figure 1A). Glucose, galactose, arabinose, rutinose, rhamnose and xylose are the sugars most commonly attached, as mono-, di- or tri-saccharides, to the 3-position on the C ring or the 5- or 7-position on the A ring. The sugar moieties can be further acylated with aliphatic and aromatic acids. Several anthocyanidins can be synthesized, differing in the substituent groups on the structural rings, but six of them represent 90% of the total, namely pelargonidin, cyanidin, delphinidin, peonidin, petunidin and malvidin [2]. Glucose represents the main glycosylating agent, and the 3-O-glucose derivatives are the most common anthocyanins found in nature [3,4] (Figure 1A).
Anthocyanins’ stability can be affected by different factors, including pH, temperature, concentration, light, oxygen, presence of other flavonoids or metallic ions [7]. In aqueous solution, anthocyanins can assume four molecular structures according to pH [8]. In acidic solutions (pH 1–3), they exist primarily as 2-phenylbenzopyrylium (flavylium) cations (red), the most stable forms. Progressively increasing pH above 4, anthocyanins adopt the form of the carbinol pseudobase (colourless) and chalcone (yellowish). In basic conditions, the predominant form is the quinoidal base (blue). Other factors, such as degree of hydroxylation or methylation and glycosylation patterns of the aromatic rings, can also affect the colour, with more hydroxyl groups giving a bluish shade, and more methoxyl groups increasing redness [8]. The aglycone forms are highly unstable and rarely found in nature, whereas glycosylation and esterification with organic and phenolic acids increase stability. On the contrary, stability is decreased by B-ring hydroxylation [9]. The formation of complexes with other flavonoids (copigmentation) can further stabilize anthocyanins.
The chemical structure of the different anthocyanin molecules affects their corresponding chemical activities, particularly in terms of antiradical and antioxidant properties, which represent a key mechanism through which anthocyanins can be beneficial for human health [10]. Substituents on the flavylium cation strongly influence the radical scavenging activity [11]; hydroxyl and methoxyl groups are electron-donating structures, and therefore their type, number and position are very important in relation to the antioxidant properties [12,13]. On the contrary, glycosylation, by reducing free hydroxyls and metal chelation sites, reduces the antioxidant power [8].
Anthocyanins provide many health benefits, from anti-inflammatory and anti-carcinogenic to antimicrobial, neuroprotective and anti-obesity effects [14]. As a consequence, their consumption can be helpful in reducing the incidence of cardiovascular, metabolic and degenerative or chronic diseases and of certain types of cancer. The strong antioxidant capacity represents the main mechanism of action. However, in some body compartments, e.g., in the venous system, their concentrations seem too low to allow scavenging of reactive oxygen species (ROS), whereas they would be adequate to influence signal transduction and gene expression pathways [15].
Anthocyanins are usually assumed with the diet. Rich sources are mostly represented by red and purple fruits or dark vegetables (e.g., berries, cherries, plums, grapes, black beans, red onions, eggplant, red cabbage, purple sweet potatoes) [16], where they can reach up to 1% of dry weight (DW) [17]. However, anthocyanins from fruits and vegetables are not the same, as their molecules are in general more glycosylated and contain more aromatic acyl groups in vegetables than in fruits [18]. Anthocyanins can enter human diet also through processed foods and beverages, such as red wine, juices and yogurt. Their intake in diet is strongly influenced by eating habits, and their highest consumption is associated with diets rich in fruit and vegetables and red wines, such as those common in the Mediterranean countries [19].
The beneficial effects of anthocyanin-enriched foods also depend on the bioavailability of these compounds, that is, the rate and extent to which they or their active metabolites become available at the sites of action within the human body. Many studies have been recently carried out highlighting the crucial role of the digestion process [7]. Anthocyanins can be absorbed from the stomach and the intestines, either as intact molecules or after degradation. The structure of the molecule, and in particular the glycone (the sugar moiety) and the presence of acylated groups, affects the rate and extent of absorption, which is generally lower for the more complex structures [20,21,22]. Anthocyanins can be rapidly absorbed from the stomach and can enter the systemic circulation within minutes, where they reach maximum concentrations after a few hours, then rapidly decline [23]. The gastrointestinal mucosa thus appears highly permeable to these molecules and the existence of active transporters has been hypothesized [24,25,26]. Anthocyanin concentrations are not the same in the different compartments; they can achieve micromolar values in the intestinal tissues, while maximum plasma levels are in the nanomolar range [15]. Moreover, it is probable that anthocyanins are extensively metabolized before entering the systemic circulation since some of their metabolites (e.g., phenolic acids) are generally more concentrated than the original compounds [27]. In studies with animal models, intact anthocyanins have been found in kidney or liver as well as in the brain [28,29]. They can finally reach the large intestine and be partially decomposed here by the microbiota, giving rise to products which may contribute to their health effects [30,31,32].

2. Purple Tomatoes: Their Origins and Specificities

Tomato is the second most cultivated vegetable worldwide and one of the most consumed, both fresh and processed [33]. Therefore, tomato fruits represent one of the main sources of carotenoids, polyphenols and vitamins of the human diet, even if the concentrations of bioactive compounds are not as high as those of other vegetables [34].
With domestication, several different tomato varieties have been developed all over the world, differing in fruit size, shape and colour [35]. The nutraceutical value of tomato fruits relies on their content of carotenoids, polyphenols, soluble sugars, organic acids, minerals and vitamins, particularly vitamin C and vitamin E [33,36,37], as well as of volatile compounds [38]. Their antioxidant capacity depends on both lipophilic (carotenoids and vitamin E) and hydrophilic (vitamin C and phenolic compounds) fractions [39]. Both composition and nutritional value are highly affected by genotype as well as nutrition and cultivation environment [40,41]. Pre- and post-harvest processing operations [42] can represent other important factors.
Carotenoids represent the main secondary metabolites in tomatoes, with the red lycopene as the most abundant one, followed by the colourless phytoene and phytofluene and the orange β-carotene (Table 1). Lycopene content increases during ripening, as the concentration of chlorophylls decrease, and it is higher in the pericarp [43,44]. Lycopene is a strong antioxidant compound, with a very important role in the prevention of several diseases [44,45].
Polyphenolic compounds include flavonols and their derivatives, hydroxycinnamic acids and flavanones [41,46] (Table 1). Naringenin chalcone (a flavonoid biosynthetic pathway intermediate) is the most abundant, followed by rutin, which is responsible for the yellow colour of the peel. Rutin is a glycosylated derivative of quercetin, which represents the main flavonol of tomatoes. The flavanone naringenin is present at lower concentrations, as well as other flavonols, such as kaempferol and myricetin. Hydroxycinnamic acids mainly include chlorogenic and caffeic acids, but also p-coumaric and ferulic acids, which are quite common in tomato. Remarkably, the flavonoid pathway is active only in the fruit peel [47,48], where flavonols and their derivatives can be accumulated [49]. Anthocyanins are not synthesized in tomato fruits, due to mutations in regulatory genes of their specific biosynthetic pathway [5]. On the contrary, they are produced in tomato vegetative tissues [50], provided that adequate developmental and environmental stimuli are present.
Due to the increasingly acknowledged health beneficial role of anthocyanins, several attempts to activate their biosynthetic pathway in tomato fruits have been successfully made in recent years, either with genetic engineering or traditional breeding approaches [51].
After some preliminary attempts [5], the first “purple” engineered tomatoes were produced in 2008, when two transcription factor-encoding genes from snapdragon, Delila (Del) and Rosea1 (Ros1), were expressed in the cultivar MicroTom under a fruit-specific promoter [52]. The high anthocyanin concentrations reached in these fruits determined an intense purple coloration in both peel and flesh, enhancing in a significant way their hydrophilic antioxidant power. The activation of the biosynthetic pathway led to the synthesis of different compounds, with delphinidin-3–(trans-p-coumaroyl)-rutinoside-5-glucoside and petunidin-3-(trans-p-coumaroyl)-rutinoside-5-glucoside as major molecules [53] (Table 2). The same exogenous gene combination was expressed in other tomato varieties with similar results [52,54].
By using a multi-level genetic engineering approach [55], the content of anthocyanins was then almost doubled in transgenic Del/Ros1 tomato lines by concomitantly expressing the Arabidopsis thaliana MYB12 gene, able to activate the upstream reactions from primary metabolism to flavonoid biosynthesis (Table 2).
An alternative strategy to obtain anthocyanin-rich tomatoes has been the breeding approach, made possible by the existence of wild Solanum species bearing fruits that synthesize anthocyanins under suitable conditions [5,51]. Different genetic combinations were obtained by crossing S. lycopersicum with different interfertile wild species. The most stable anthocyanin-rich fruit genotypes were those homozygous for both Anthocyanin fruit (Aft) [56] and atroviolacea (atv) [57] alleles (Table 2). Differently from the engineered tomatoes, the anthocyanin phenotype in these fruits is limited to fruit peel and is environmentally dependent, being particularly induced under high light and low temperatures [48,58]. As a consequence, the quantity of pigments inversely correlates with fruit size—the maximum amounts (up to 300 mg 100 g−1 FW) could be reached by small fruits, where the ratio peel/flesh was higher [58]. Carotenoid levels in these fruits were similar to those in non-anthocyanin ones, indicating that the increased flux of metabolites into the flavonoid pathway was not detrimental to the carotenoid synthesis. From the Aft/Aft · atv/atv starting breeding material [58], the “Indigo Rose” purple tomato lines were bred [59].
A second independently developed Aft/Aft · atv/atv genotype was named “Sun Black” (SB) for the light conditional purple fruits [48,51,60] (Figure 1B). In SB, the content of anthocyanins could reach more than 1 mg g−1 DW and the two main molecules identified were petunidin-3-(trans-p-coumaroyl)-rutinoside-5-glucoside (56.6% of the total) and malvidin-3-(trans-p-coumaroyl)-rutinoside-5-glucoside (21.4%) [6] (Table 2). In this line, other flavonoids increased, compared to the non-anthocyanin background, in proportion to the anthocyanin concentration, with rutin reaching 0.8 mg g−1 DW and a total phenolic content of 8.6 mg g−1 DW. Consequently, the antioxidant capacity of the hydrophilic extract was significantly high. Total carotenoid content, exceeding 200 µg g−1 DW, remained similar to non-anthocyanin varieties, whereas the amount of vitamin C (37.3 mg 100 g−1 FW) was found higher [6].
The line V118, whose genotype was not made known, was also developed using a breeding approach [61]. Similarly to the previous ones, carotenoid and polyphenol amounts and compositions in this accession did not differ significantly from other cultivated varieties, with the exception of the presence of anthocyanins, which mainly resulted in acylglycosides of petunidin and malvidin (Table 2). The phenolic compounds represented the major contributors to the antioxidant power measured in V118 purple tomatoes [61]. Successive studies carried out on this line [64] indicated the good bioavailability of the anthocyanin fraction in a cell-based antioxidant assay. Furthermore, in a simulated gastrointestinal digestion model, it was found that both the carotenoid and the phenolic profiles significantly changed during digestion, indicating the occurrence of a strong degradation process. This also affected the lipophilic and hydrophilic antioxidant activities of V118 fruits. The anthocyanin fraction, however, reduced in quantity but not in its composition, suggesting that a significant degradation did not occur during digestion.
A high-anthocyanin breeding line further described was a “blue” tomato, corresponding to a cultivar of “Indigo Rose” [59] cultivated in Japan [62]. In this cv., several eleven types of anthocyanins were identified, including five delphinidin-, four petunidin- and four malvidin-derived, mostly accumulated in the peel (Table 2). The antioxidant activity of the blue tomato peel extract was highly dependent on the anthocyanin content and similar to that of strawberry fruits, and half if compared with that of blueberries [62].
In order to maximize the nutraceutical properties of tomato fruits, increasing both anthocyanins and carotenoids, breeding programs were also carried out by using “high pigment” (hp) mutants to be crossed with high-anthocyanin accessions [58,65]. Very interesting results were obtained in terms of anthocyanin accumulation as well as carotenoid and vitamin C contents, with the introgression in the same background of different mutations increasing the content of specific phytonutrients [66] (Figure 1B). The combination of the alleles hp2, Aft and atv in a cherry tomato background, in particular, led to uniformly purple fruits with total enhanced nutrient contents [63] (Table 2). However, these allele introgressions also led to changes in volatile compounds, particularly enriched by phenolic profiles, which could modify the typical tomato flavour and are therefore worthy of further studies [63].
To summarize, independently from their genotypes, purple tomato lines obtained by breeding material maintained the original content of the tomato bioactive compounds and were characterized by the accumulation of anthocyanidins in the peel, which mainly belong to petunidin, malvidin and delphinidin classes, the same that can be found in tomato vegetative tissues [50]. One of the most common and abundant anthocyanin molecules identified in purple tomatoes was petunidin-3-(trans-p-coumaroyl)-rutinoside-5-glucoside (Figure 1C). The antioxidant power of these fruits was higher than in non-anthocyanin varieties, because they summed a higher hydrophilic activity due to the polyphenolic fraction to the lipophilic antioxidant activity of the carotenoids. The concentration of anthocyanins varied according to fruit size and light exposition and could reach considerable values (more than 1 mg g−1 DW). The purple tomato lines produced by genetic engineering further maximized all these aspects, being characterized by a uniform phenotype with high anthocyanin concentrations in both peel and flesh. However, whereas some purple bred-tomato varieties have been already patented and marketed, none of the GMO genetically engineered lines are commercially available yet.

3. Anthocyanins from Purple Tomatoes and Human Health

In parallel with the research activities aimed at producing new anthocyanin-rich tomato lines, several studies were carried out to characterize the pharmacological activities of these fruits by in vitro and in vivo studies. In many cases, direct comparison between purple tomatoes and their non-anthocyanin backgrounds allowed the identification of effects specifically exerted by the anthocyanin fraction, thus demonstrating the added nutraceutical value that these pigments can offer.
As mentioned before, several health beneficial effects are currently accredited to anthocyanins, and pigments from different sources, in particular berries, have been tested for their pharmacological effects (recently reviewed in [67,68]). Due to the anthocyanin-rich tomatoes’ recent origin, epidemiological studies on such tomatoes are still scarce. We review what is currently known in the following paragraphs.
Antitumor activity. The beneficial role of tomato consumption in terms of reduced cancer incidence, thanks to their content of carotenoids and polyphenols, is well known [44]. However, anthocyanins from many different sources have also demonstrated anti-carcinogenic activity and multiple and overlapping mechanisms of action have been proposed, specifically in the different phases of cancer development and progression (extensively reviewed in [69]). In the initial stage of tumorigenesis, anthocyanins, due to their strong antioxidant capacity, may protect cellular genomes from possible DNA damage and gene mutations induced by oxidative stress or other mutagens, thus preventing the transformation of normal cells into cancer cells. Moreover, anthocyanins can control the expression and secretion of inflammatory factors, whose continuous or increased production may induce chronic inflammation processes, leading in many cases to tumour development (see also next paragraphs). In the cancer formation stage, anthocyanins can induce terminal differentiation of tumour cells, through their differentiation towards normal and mature cells, thus blocking tumorigenesis. They can also inhibit cellular transformation, a mechanism that is often associated with tumour development induced by inflammation signalling pathways, as well as cellular proliferation, that is, the uncontrolled cell cycle, characterized by continuous divisions, that is typical of cancer cells. This occurs due to the ability of anthocyanins to inhibit different kinase signalling pathways, and to arrest the cell cycle at different division phases. In the cancer developmental stage, anthocyanins can induce apoptosis of malignant cells through mechanisms involving different pathways (e.g., mitochondrial signalling pathway, caspase-dependent and -independent signalling pathways, endoplasmic reticulum signalling pathway). Finally, anthocyanins are potential antiangiogenic agents and thus may prevent the formation of new blood vessels that, by supplying oxygen to the tumour cells, represent an important factor in cancer development.
The recent studies carried out on the anthocyanin fractions isolated from purple tomatoes supported these lines of evidence, in particular the specific anti-proliferative effects against different types of tumour cell lines both in vitro and in vivo. One of the first indications came from the Del/Ros1 purple tomatoes that, in a pilot test administered to cancer-susceptible Trp53–/– mice, led to a significant extension of their life span [52]. Subsequently, extracts from SB tomato were tested in vitro for proliferation inhibitory effects on human colon (HT-29) and ovarian (HeLa) cancer cells [60]. They showed a significant anti-proliferative action on both kinds of cells in a dose-dependent manner, and this effect appeared genotype-specific because anthocyanin-rich extracts from eggplant, red grape and red cabbage did not show the same effectiveness. This was probably due to the differences in the extracts’ composition; different anthocyanidin structures can indeed show different biological activity as well as a different susceptibility to cell uptake [70,71].
Photoprotection. The beneficial effect of anthocyanins on vision and visual acuity has been known for a very long time [72,73]. Recent evidence confirms that intact anthocyanins and their metabolites can pass through the blood–brain and the blood–retinal barriers in animal models and their concentrations in several ocular tissues can be higher than in plasma, suggesting that they can concentrate there [74]. Anthocyanins can exert different effects on vision health, as attested by many recent studies (reviewed in [74]): (i) they showed relaxing activities on ciliary smooth muscle, which is involved in the control of lens focus, in the production of aqueous humour and in the maintenance of ocular pressure, thus demonstrating possible therapeutic uses in the treatment of visual fatigue and important ocular disorders such as myopia and glaucoma; (ii) they stimulated the regeneration of rhodopsin, after being photo-bleached by light, a mechanism that is necessary to make this photoreceptor active to carry out again its function in the visual photo transduction process; (iii) being able to inhibit the elongation of axial and ocular lengths caused by wearing a negative lens in animal models, they could be useful in the prevention of myopia, a very common cause of impaired vision in young and adult people, due to a refractive error induced by the elongation or curvature of the eye shape; (iv) they improved dark adaptation and night vision by the enhanced generation of retinal pigments; and (v) they increased retinal blood circulation and could therefore be useful in preventing the early stages of diabetic retinopathy or glaucoma. The antioxidant and scavenging activities of anthocyanins could also affect the production of ROS inducing the apoptotic degeneration of the photoreceptor cells, which is responsible for the gradual constriction of the central visual field, leading to blindness in retinitis pigmentosa [75,76]. In this context, the extract of the Japan blue tomato was tested in vitro on murine photoreceptor cells and found to significantly reduce cone cell death by scavenging hydrogen peroxide [62]. This was attributed to the anthocyanin fraction, whereas lycopene showed no effect. This study indicated that petunidin-derived anthocyanins, the most abundant in Japan blue tomato extract, could inhibit ROS production due to their scavenging activities, supporting previous positive results obtained in similar models with other kinds of anthocyanin molecules, such as malvidin glycosides from Chinese blueberries [77] and delphinidin glycosides from Maqui berries [78].
Anti-inflammatory activities. Inflammation is a complex response of the immune system through which the animal body may fight infections, injuries, toxins or other stress events. In the acute inflammation process, cell surface receptors recognize the detrimental stimuli, with the activation of inflammatory pathways characterized by the release of inflammatory markers from the injured cells. These markers include inflammatory cytokines, nitric oxide (NO), interleukins, tumour necrosis factor-alpha (TNF-α), interferon gamma and prostaglandins. Finally, inflammatory cells, such as leukocytes, are recruited from the venous system to the injured tissue [79]. All these events contribute to the restoration of tissue homeostasis and the resolution of the acute inflammation. When this does not occur, a long-term reaction to an inflammatory stimulus accompanied by changes aimed at wound healing can lead to a chronic inflammation. This in turn can create conditions able, with time, to trigger a chronic disease such as an autoimmune disease, a metabolic disorder (atherosclerosis and obesity), fibrosis or certain types of cancer [80]. Fighting the acute inflammation causes and interfering with the inflammatory cascades may help in preventing such important pathologies. In this context, several phytochemicals showed anti-inflammatory actions and anthocyanins appeared effective in the inhibition of signalling cascades involving cytokines, NO production and expression of some pro-inflammatory genes [81]. Cyanidin glycosides, in particular, were able to inhibit cyclooxygenase enzyme activities that are necessary to convert arachidonic acid to pro-inflammatory cytokines (prostaglandins), which play a fundamental role in the inflammation response [82].
The anti-inflammatory potential of purple tomatoes was analysed in several studies. Extracts from V118 tomatoes, for example, were tested in vivo in the carrageenan-induced paw oedema rat model [64]. This phlogistic model is commonly used to investigate new anti-inflammatory drugs and has been used to evaluate the anti-inflammatory activity of other tomato phytochemicals. Lycopene, in particular, was able to significantly inhibit paw oedema formation in both acute and chronic treatments [83]. Carrageenan in rats leads to increases in paw volume through the induction of an inflammatory process characterized by two distinct phases. In the first two hours, inflammation mediators are released, then ROS such as hydrogen peroxide and superoxide radical, as well as prostaglandins, are produced [83]. Moreover, inflamed tissue attacked from free radicals accumulate malondialdehyde (MDA), an end product of lipid peroxidation, and NO, while trying to counteract oxidative stress by inducing the activities of antioxidant enzymes such as glutathione peroxidase (GPx) and superoxide dismutase (SOD) [84]. V118 purple tomato extracts showed significant and dose-dependent anti-inflammatory effects (Figure 2), in addition to those exerted by the other tomato phytochemicals, i.e., carotenoids and other phenolic compounds [64]. These effects resulted in both direct and indirect antioxidant activities in oedematous tissue, with scavenging of free oxygen and nitrogen radicals, reduction of MDA production and increase of GPx and SOD enzymatic activities.
Genetically engineered “Indigo” tomatoes, characterized by high anthocyanin and flavonol contents, as well as other polyphenol-enriched tomato lines, were tested in a spontaneous ulcerative colitis mouse model for their potential effects on the host gut microbiota, inflammatory responses and the symptoms of inflammatory bowel diseases (IBDs), a group of common chronic intestinal inflammation syndromes associated with intestinal dysbiosis [86,87]. Two-week diets supplemented with polyphenol-enriched tomatoes were able to change the composition of the gut microbiota in healthy mice [86], as well as the dysbiotic intestinal microbiota communities in the colitis mouse model [87]. Polyphenol-enriched diets thus created unfavourable conditions for distinct bacterial species. Suppression of the production of pro-inflammatory cytokines also indicated induction of an anti-inflammatory pathway [86]. Finally, it was demonstrated that the observed effects specifically related to the particular combination of the different polyphenolic classes present in these tomato fruits, acting synergistically, rather than to single specific molecules. The positive anti-inflammatory effects of the anthocyanin fraction were thus maximised here by the food matrix context.
A parallel study focused on the effects of anthocyanins and flavonols on the pro-inflammatory signalling pathways associated with IBDs, by using a murine colonic epithelial cell-based inflammatory assay [88]. A dysregulation of the intestinal immune response to resident intestinal microbes, altering the delicate equilibrium between immunogenicity against pathogens and tolerance of the commensal microbiota, is among the possible causes of IBDs [89]. Extracts from engineered high-anthocyanin and high-flavonol tomatoes were able to inhibit (significantly more than non-anthocyanin tomato controls) the epithelial secretion of a set of pro-inflammatory cytokines and chemokines mediating interaction between the gut epithelium cells and the underlying mucosal dendritic cells (DCs), which are effectors of both innate and adaptive immune responses [88]. This had the effect of reducing influx and accumulation of DCs into the gut mucosa, a process which plays a key role in the pathogenesis of colitis [90]. Moreover, flavonoids from engineered tomatoes significantly reduced the activation of SAPK/JNK and p38 MAPK pathways [88], both important in the regulation of pro-inflammatory responses in IBDs [91,92,93]. In the end, anthocyanins and flavonols modulated epithelial cells to become hyporesponsive to bacterial stimulation.
Cardiovascular protection. Several recent epidemiological studies have demonstrated that the consumption of polyphenol-rich foods may induce beneficial effects in pathways related to cardiovascular health. Anthocyanin intake, in particular, positively correlated with a reduction in cardiovascular risk [94], both improving vascular function and reducing atherosclerotic plaque development [95,96,97]. As is the case for other beneficial effects, the cardiovascular protection exerted by anthocyanins was firstly ascribed to their antioxidant nature, allowing them to delay the progression of atherosclerosis due to the scavenging activity against the oxidation of low-density lipoprotein cholesterol and associated inflammatory processes [98]. However, anthocyanins seem to be involved in more complex molecular mechanisms. Recent studies have demonstrated their ability to reduce the adhesion of human circulating monocytes to inflamed endothelial cells, which represents one of the initial steps of the atherosclerotic process [99]. Moreover, increasing evidence has indicated that anthocyanins can also modulate the expression of genes encoding enzymes involved in antioxidant defences or the expression of microRNA acting in the regulation of cellular processes like inflammation and apoptosis. They were also found to regulate cell-signalling pathways, e.g., based on phosphorylation events [100].
In a study carried out by Blando and colleagues [10], purified anthocyanin samples (PASs), differing in composition from various plant materials including SB purple tomatoes, were compared in terms of radical scavenging and anti-inflammatory activities in human endothelial cells. A model of vascular inflammation, represented by cultured human microvascular endothelial cells-1 treated with the pro-inflammatory mediator TNF-α, was used in the study. Endothelial cells were pre-exposed to the different PASs, and the relative anti-inflammatory properties were evaluated by measuring their ability to inhibit TNF-α-stimulated expression of two endothelial adhesion molecules, namely the vascular cell adhesion molecule-1 and the intercellular adhesion molecule-1, two crucial vascular inflammatory antigens [101]. All the different PASs showed anti-inflammatory properties, but the anthocyanin chemical structures affected the results [10]. Anthocyanins were more effective when non-acylated (e.g., PASs from mahaleb cherry and blackcurrant) than when acylated (e.g., PASs from black carrot and SB tomato). These differences could be partially explained considering the relative antioxidant capacities, since the non-acylated anthocyanins showed the highest activities. However, since the different PASs were administered at the same concentrations, the lower molar concentrations of the acylated anthocyanins (characterized by higher molecular weights) could have in part affected their efficacy. In any case, anthocyanins showed anti-inflammatory and anti-atherosclerotic effects in this study, supporting the previous evidence on the positive roles they may play in cardiovascular protection.

4. Conclusions

Although the pharmacological effects of the specific classes of anthocyanins accumulated in purple tomatoes have not been completely characterized and the number of epidemiological studies carried out with this “new” source of anthocyanins is still low, the first results obtained in both in vitro and in vivo research studies nevertheless support what was already known from larger and more consolidated works (Figure 3). Anthocyanin intake from purple tomatoes, particularly from the breeding lines able to accumulate the pigments only in the peel, cannot reach the amounts characterizing other traditional sources, such as berries. However, tomato consumption is high and almost daily in many human diets, thanks to both fresh and processed products. Purple tomato consumption could thus easily guarantee a habitual anthocyanin supply without changing eating habits and in a rich food matrix context, which can offer extra values for the synergistic actions of all its phytochemical components, certainly not obtainable through pharmacological supplements. All the experimental results obtained so far thus appear very promising for the valorisation of purple tomatoes as a functional food.
Future research in the plant biology field will be needed to further increase the amount of anthocyanins in tomato fruits, inducing, for example, their biosynthetic pathway also in the flesh (which could allow the use of purple tomatoes not only as fresh but also as processed products) or making more uniform their synthesis on the peel [5]. Moreover, it can be envisaged that additional studies will be carried out on the nutraceutical value of these vegetables, with new and more in-depth research on the peculiar mechanisms of action of the anthocyanin fraction they contain, as well as preclinical and clinical trials to better evaluate their health beneficial effects.

Author Contributions

S.G. and P.P. conceived the review; S.G. drafted the paper; and P.P. provided critical feedback. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Acknowledgments

We acknowledge L.E. Pereira Peres from Universidade de São Paulo, Brazil, for kindly providing us with seeds of the Aft/Aft atv/atv hp2/hp2 line in MT background.

Conflicts of Interest

S.G. and P.P. are among the authors of the “Solenero” tomato varieties, derived from the Sun Black original breeding material.

References

  1. Liu, Y.; Tikunov, Y.; Schouten, R.E.; Marcelis, L.F.M.; Visser, R.G.F.; Bovy, A. Anthocyanin biosynthesis and degradation mechanisms in solanaceous vegetables: A review. Front. Chem. 2018, 6, 52. [Google Scholar] [CrossRef] [PubMed]
  2. Wallace, T.C.; Giusti, M.M. Anthocyanins. Adv. Nutr. 2015, 6, 620–622. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Andersen, Ø.M.; Jordheim, M. The anthocyanins. In Flavonoids: Chemistry, Biochemistry and Applications, 2nd ed.; Andersen, Ø.M., Markham, K.R., Eds.; CRC Press: Boca Raton, FL, USA, 2006; pp. 452–471. [Google Scholar]
  4. Kong, J.M.; Chia, L.S.; Goh, N.K.; Chia, T.F.; Brouillard, R. Analysis and biological activities of anthocyanins. Phytochemistry 2003, 64, 923–933. [Google Scholar] [CrossRef]
  5. Colanero, S.; Perata, P.; Gonzali, S. What’s behind purple tomatoes? Insight into the mechanisms of anthocyanin synthesis in tomato fruits. Plant. Physiol. 2020, 182, 1841–1853. [Google Scholar] [CrossRef] [Green Version]
  6. Blando, F.; Berland, H.; Maiorano, G.; Durante, M.; Mazzucato, A.; Picarella, M.E.; Nicoletti, I.; Gerardi, C.; Mita, G.; Andersen, Ø.M. Nutraceutical characterization of anthocyanin-rich fruits produced by “Sun Black” tomato line. Front. Nutr. 2019, 6, 133. [Google Scholar] [CrossRef] [Green Version]
  7. Fang, J. Bioavailability of anthocyanins. Drug Metab. Rev. 2014, 46, 508–520. [Google Scholar] [CrossRef]
  8. Miguel, M.G. Anthocyanins: Antioxidant and/or anti-inflammatory activities. J. Appl. Pharm. Sci. 2011, 1, 7–15. [Google Scholar]
  9. Woodward, G.; Kroon, P.; Cassidy, A.; Kay, C. Anthocyanin stability and recovery: Implications for the analysis of clinical and experimental samples. J. Agric. Food Chem. 2009, 57, 5271–5278. [Google Scholar] [CrossRef]
  10. Blando, F.; Calabriso, N.; Berland, H.; Maiorano, G.; Gerardi, C.; Carluccio, M.A.; Andersen, Ø.M. Radical scavenging and anti-inflammatory activities of representative anthocyanin groupings from pigment-rich fruits and vegetables. Int. J. Mol. Sci. 2018, 19, 169. [Google Scholar] [CrossRef] [Green Version]
  11. Azevedo, J.; Fernandes, I.; Faria, A.; Oliveira, J.; Fernandes, A.; de Freitas, V.; Mateus, N. Antioxidant properties of anthocyanidins, anthocyanidins 3-glucosides and respective portisins. Food Chem. 2010, 119, 518–523. [Google Scholar] [CrossRef]
  12. Rice-Evans, C.A.; Miller, N.J.; Paganga, G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med. 1996, 20, 933–956. [Google Scholar] [CrossRef]
  13. Ali, M.H.; Almagribi, W.; Al-Rashidi, M.N. Antiradical and reductant activities of anthocyanidins and anthocyanins, structure-activity relationship and synthesis. Food Chem. 2016, 194, 1275–1282. [Google Scholar] [CrossRef] [PubMed]
  14. Smeriglio, A.; Barreca, D.; Bellocco, E.; Trombetta, D. Chemistry, pharmacology and health benefits of anthocyanins. Phytother. Res. 2016, 30, 1265–1286. [Google Scholar] [CrossRef] [PubMed]
  15. Milbury, P.E.; Vita, J.A.; Blumberg, J.B. Anthocyanins are bioavailable in humans following an acute dose of cranberry juice. J. Nutr. 2010, 140, 1099–1104. [Google Scholar] [CrossRef] [Green Version]
  16. Wu, X.; Beecher, G.R.; Holden, J.M.; Haytowitz, D.B.; Gebhardt, S.E.; Prior, R.L. Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption. J. Agric. Food Chem. 2006, 54, 4069–4075. [Google Scholar] [CrossRef]
  17. Pojer, E.; Mattivi, F.; Johnson, D.; Stockley, C.S. The case for anthocyanin consumption to promote human health: A review. Compr. Rev. Food Sci. Food Saf. 2013, 12, 483–508. [Google Scholar] [CrossRef]
  18. Andersen, Ø.M.; Jordheim, M. Basic anthocyanin chemistry and dietary sources. In Anthocyanins in Health and Disease; Wallace, T.C., Giusti, M.M., Eds.; Taylor & Francis Inc.: Abingdon, UK; CRC Press: New York, NY, USA, 2013; pp. 13–90. [Google Scholar]
  19. Zamora-Ros, R.; Knaze, V.; Luján-Barroso, L.; Slimani, N.; Romieu, I.; Touillaud, M.; Kaaks, R.; Teucher, B.; Mattiello, A.; Grioni, S.; et al. Estimation of the intake of anthocyanidins and their food sources in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Br. J. Nutr. 2011, 106, 1090–1099. [Google Scholar] [CrossRef] [Green Version]
  20. Tian, Q.G.; Giusti, M.M.; Stoner, G.D.; Schwartz, S.J. Urinary excretion of black raspberry (Rubus occidentalis) anthocyanins and their metabolites. J. Agric. Food Chem. 2006, 54, 1467–1472. [Google Scholar] [CrossRef]
  21. Wu, X.L.; Pittman, H.E.; Mckay, S.; Prior, R.L. Aglycones and sugar moieties alter anthocyanin absorption and metabolism after berry consumption in weanling pigs. J. Nutr. 2005, 135, 2417–2424. [Google Scholar] [CrossRef]
  22. Kurilich, A.C.; Clevidence, B.A.; Britz, S.J.; Simon, P.W.; Novotny, J.A. Plasma and urine responses are lower for acylated versus nonacylated anthocyanins from raw and cooked purple carrots. J. Agric. Food Chem. 2005, 53, 6537–6542. [Google Scholar] [CrossRef]
  23. Milbury, P.E.; Cao, G.H.; Prior, R.L.; Blumberg, J. Bioavailablility of elderberry anthocyanins. Mech. Ageing Dev. 2002, 123, 997–1006. [Google Scholar] [CrossRef]
  24. Passamonti, S.; Vrhovsek, U.; Mattivi, F. The interaction of anthocyanins with bilitranslocase. Biochem. Biophys. Res. Commun. 2002, 296, 631–636. [Google Scholar] [CrossRef]
  25. Faria, A.; Pestana, D.; Azevedo, J.; Martel, F.; de Freitas, V.; Azevedo, I.; Mateus, N.; Calhau, C. Absorption of anthocyanins through intestinal epithelial cells—Putative involvement of GLUT2. Mol. Nutr. Food Res. 2009, 53, 1430–1437. [Google Scholar] [CrossRef]
  26. Dreiseitel, A.; Oosterhuis, B.; Vukman, K.V.; Schreier, P.; Oehme, A.; Locher, S.; Hajak, G.; Sand, P.G. Berry anthocyanins and anthocyanidins exhibit distinct affinities for the efflux transporters BCRP and MDR1. Br. J. Pharm. 2009, 158, 1942–1950. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Mallery, S.R.; Budendorf, D.E.; Larsen, M.P.; Pei, P.; Tong, M.; Holpuch, A.S.; Larsen, P.E.; Stoner, G.D.; Fields, H.W.; Chan, K.K.; et al. Effects of human oral mucosal tissue, saliva, and oral microflora on intraoral metabolism and bioactivation of black raspberry anthocyanins. Cancer Prev. Res. 2011, 4, 1209–1221. [Google Scholar] [CrossRef] [Green Version]
  28. Passamonti, S.; Vrhovsek, U.; Vanzo, A.; Mattivi, F. Fast access of some grape pigments to the brain. J. Agric. Food Chem. 2005, 53, 7029–7034. [Google Scholar] [CrossRef]
  29. Talavera, S.; Felgines, C.; Texier, O.; Besson, C.; Gil-Izquierdo, A.; Lamaison, J.L.; Rémésyet, C. Anthocyanin metabolism in rats and their distribution to digestive area, kidney, and brain. J. Agric. Food Chem. 2005, 53, 3902–3908. [Google Scholar] [CrossRef]
  30. Gonzalez-Barrio, R.; Edwards, C.A.; Crozier, A. Colonic catabolism of ellagitannins, ellagic acid, and raspberry anthocyanins: In vivo and in vitro studies. Drug Metab. Dispos. 2011, 39, 1680–1688. [Google Scholar] [CrossRef]
  31. Kahle, K.; Kraus, M.; Scheppach, W.; Ackermann, M.; Ridder, F.; Richlinget, E. Studies on apple and blueberry fruit constituents: Do the polyphenols reach the colon after ingestion? Mol. Nutr. Food Res. 2006, 50, 418–423. [Google Scholar] [CrossRef]
  32. Stalmach, A.; Edwards, C.A.; Wightman, J.D.; Crozier, A. Gastrointestinal stability and bioavailability of (poly)phenolic compounds following ingestion of Concord grape juice by humans. Mol. Nutr. Food Res. 2012, 56, 497–509. [Google Scholar] [CrossRef]
  33. Quinet, M.; Angosto, T.; Yuste-Lisbona, F.J.; Blanchard-Gros, R.; Bigot, S.; Martinez, J.P.; Lutts, S. Tomato fruit development and metabolism. Front. Plant. Sci. 2019, 10, 1554. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Chun, O.K.; Kim, D.O.; Smith, N.; Schroeder, D.; Han, J.T.; Lee, C.Y. Daily consumption of phenolics and total antioxidant capacity from fruit and vegetables in the American diet. J. Sci. Food Agric. 2005, 85, 1715–1724. [Google Scholar] [CrossRef]
  35. Bhattarai, K.; Sharma, S.; Panthee, D.R. Diversity among modern tomato genotypes at different levels in fresh-market breeding. Int. J. Agron. 2018, 4170432. [Google Scholar] [CrossRef] [Green Version]
  36. Leiva-Brondo, M.; Valcárcel, M.; Cortés-Olmos, C.; Roselló, S.; Cebolla-Cornejo, J.; Nuez, F. Exploring alternative germplasm for the development of stable high vitamin C content in tomato varieties. Sci. Hortic. 2012, 133, 84–88. [Google Scholar] [CrossRef]
  37. Raiola, A.; Tenore, G.C.; Barone, A.; Frusciante, L.; Rigano, M.M. Vitamin E content and composition in tomato fruits: Beneficial roles and bio-fortification. Int. J. Mol. Sci. 2015, 16, 29250–29264. [Google Scholar] [CrossRef] [Green Version]
  38. Wang, D.; Seymour, G.B. Tomato flavor: Lost and found? Mol. Plant. 2017, 10, 782–784. [Google Scholar] [CrossRef] [Green Version]
  39. Ilić, Z.; Aharon, Z.; Perzelan, Y.; Alkalai-Tuvia, S.; Fallik, E. Lipophilic and hydrophilic antioxidant activity of tomato fruit during postharvest storage on different temperatures. Acta Hortic. 2009, 830, 627–634. [Google Scholar] [CrossRef]
  40. Davies, J.N.; Hobson, G.E. The constituents of tomato fruit-the influence of environment, nutrition, and genotype. Crit. Rev. Food Sci. Nutr. 1981, 15, 205–280. [Google Scholar] [CrossRef]
  41. Martínez-Valverde, I.; Periago, M.J.; Provan, G.; Chesson, A. Phenolic compounds, lycopene and antioxidant activity in commercial varieties of tomato (Lycopersicum esculentum). J. Sci. Food Agric. 2002, 82, 323–330. [Google Scholar] [CrossRef]
  42. Tiwari, U.; Cummins, E. Factors influencing levels of phytochemicals in selected fruit and vegetables during pre- and post-harvest food processing operations. Food Res. Int. 2013, 50, 497–506. [Google Scholar] [CrossRef]
  43. Qin, J.; Chao, K.; Kim, M.S. Investigation of Raman chemical imaging for detection of lycopene changes in tomatoes during postharvest ripening. J. Food Eng. 2011, 107, 277–288. [Google Scholar] [CrossRef]
  44. Martí, R.; Roselló, S.; Cebolla-Cornejo, J. Tomato as a source of carotenoids and polyphenols targeted to cancer prevention. Cancers 2016, 8, 58. [Google Scholar] [CrossRef] [PubMed]
  45. Mozos, I.; Stoian, D.; Caraba, A.; Malainer, C.; Horbanczuk, J.O.; Atanasov, A.G. Lycopene and vascular health. Front. Pharm. 2018, 9, 1–16. [Google Scholar] [CrossRef] [PubMed]
  46. Slimestad, R.; Fossen, T.; Verheul, M.J. The flavonoids of tomatoes. J. Agric. Food Chem. 2008, 56, 2436–2441. [Google Scholar] [CrossRef]
  47. Colliver, S.; Bovy, A.; Collins, G.; Muir, S.; Robinson, S.; De Vos, C.H.; Verhoeyen, M.E. Improving the nutritional content of tomatoes through reprogramming their flavonoid biosynthetic pathway. Phytochem. Rev. 2002, 1, 113–123. [Google Scholar] [CrossRef]
  48. Povero, G.; Gonzali, S.; Bassolino, L.; Mazzucato, A.; Perata, P. Transcriptional analysis in high-anthocyanin 518 tomatoes reveals synergistic effect of Aft and atv genes. J. Plant. Physiol. 2011, 168, 270–279. [Google Scholar] [CrossRef] [PubMed]
  49. Stewart, A.J.; Bozonnet, S.; Mullen, W.; Jenkins, G.I.; Lean, M.E.; Crozier, A. Occurrence of flavonols in tomatoes and tomato-based products. J. Agric. Food Chem. 2000, 48, 2663–2669. [Google Scholar] [CrossRef]
  50. Kiferle, C.; Fantini, E.; Bassolino, L.; Povero, G.; Spelt, C.; Buti, S.; Giuliano, G.; Quattrocchio, F.; Koes, R.; Perata, P.; et al. Tomato R2R3-MYB Proteins SlANT1 and SlAN2: Same protein activity, different roles. PLoS ONE 2015, 10, e0136365. [Google Scholar] [CrossRef] [Green Version]
  51. Gonzali, S.; Mazzucato, A.; Perata, P. Purple as a tomato: Towards high anthocyanin tomatoes. Trends Plant Sci. 2009, 14, 237–241. [Google Scholar] [CrossRef] [Green Version]
  52. Butelli, E.; Titta, L.; Giorgio, M.; Mock, H.P.; Matros, A.; Peterek, S.; Schijlen, E.G.; Hall, R.D.; Bovy, A.G.; Luo, J.; et al. Enrichment of tomato fruit with health-promoting anthocyanins by expression of select transcription factors. Nat. Biotechnol. 2008, 26, 1301–1308. [Google Scholar] [CrossRef]
  53. Tohge, T.; Zhang, Y.; Peterek, S.; Matros, A.; Rallapalli, G.; Tandrón, Y.A.; Butelli, E.; Kallam, K.; Hertkorn, N.; Mock, H.P.; et al. Ectopic expression of snapdragon transcription factors facilitates the identification of genes encoding enzymes of anthocyanin decoration in tomato. Plant J. 2015, 83, 686–704. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Lim, W.; Miller, R.; Park, J.; Park, S. Consumer sensory analysis of high flavonoid transgenic tomatoes. J. Food Sci. 2014, 79, S1212–S1217. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  55. Zhang, Y.; Butelli, E.; Alseekh, S.; Tohge, T.; Rallapalli, G.; Luo, J.; Kawar, P.G.; Hill, L.; Santino, A.; Fernie, A.R.; et al. Multi-level engineering facilitates the production of phenylpropanoid compounds in tomato. Nat. Commun. 2015, 6, 8635. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Rick, C.M.; Reeves, A.F.; Zobel, R.W. Inheritance and linkage relations of four new mutants. Rep. Tomato Genet. Coop. 1968, 18, 34–35. [Google Scholar]
  57. Georgiev, C. Anthocyanin fruit (Af). Rep. Tomato Genet. Coop. 1972, 22, 10. [Google Scholar]
  58. Mes, P.J.; Boches, P.; Myers, J.R. Characterization of tomatoes expressing anthocyanin in the fruit. J. Am. Soc. Hortic. Sci. 2008, 133, 262–269. [Google Scholar] [CrossRef] [Green Version]
  59. Purple Tomato Debuts as ‘Indigo Rose’. Available online: https://extension.oregonstate.edu/news/purple-tomato-debuts-indigo-rose (accessed on 16 September 2020).
  60. Mazzucato, A.; Willems, D.; Bernini, R.; Picarella, M.E.; Santangelo, E.; Ruiu, F.; Tilesi, F.; Soressi, G.P. Novel phenotypes related to the breeding of purple-fruited tomatoes and effect of peel extracts on human cancer cell proliferation. Plant. Physiol. Biochem. 2013, 72, 125–133. [Google Scholar] [CrossRef]
  61. Li, H.; Deng, Z.; Liu, R.; Young, J.C.; Zhu, H.; Loewen, S.; Tsao, R. Characterization of phytochemicals and antioxidant activities of a purple tomato (Solanum lycopersicum L.). J. Agric. Food Chem. 2011, 59, 11803–11811. [Google Scholar] [CrossRef]
  62. Ooe, E.; Ogawa, K.; Horiuchi, T.; Tada, H.; Murase, H.; Tsuruma, K.; Shimazawa, M.; Hara, H. Analysis and characterization of anthocyanins and carotenoids in Japanese blue tomato. Biosci. Biotechnol. Biochem. 2016, 80, 341–349. [Google Scholar] [CrossRef] [Green Version]
  63. Da Silva-Souza, M.A.; Peres, L.E.P.; Freschi, J.R.; Purgatto, E.; Lajolo, F.M.; Hassimotto, N.M.A. Changes in flavonoid and carotenoid profiles alter volatile organic compounds in purple and orange cherry tomatoes obtained by allele introgression. J. Sci. Food Agric. 2020, 100, 1662–1670. [Google Scholar] [CrossRef]
  64. Li, H.; Deng, Z.; Liu, R.; Loewen, S.; Tsao, R. Bioaccessibility, in vitro antioxidant activities and in vivo anti-inflammatory activities of a purple tomato (Solanum lycopersicum L.). Food Chem. 2014, 159, 353–360. [Google Scholar] [CrossRef] [PubMed]
  65. Sapir, M.; Oren-Shamir, M.; Ovadia, R.; Reuveni, M.; Evenor, D.; Tadmor, Y.; Nahon, S.; Shlomo, H.; Chen, L.; Meir, A.; et al. Molecular aspects of Anthocyanin fruit tomato in relation to high pigment-1. J. Hered. 2008, 99, 292–303. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  66. Sestari, I.; Zsögön, A.; Rehder, G.G.; de Lira Teixeira, L.; Hassimotto, N.M.; Purgatto, E.; Benedito, V.A.; Pereira-Peres, L.E. Near-isogenic lines enhancing ascorbic acid, anthocyanin and carotenoid content in tomato (Solanum lycopersicum L. cv Micro-Tom) as a tool to produce nutrient-rich fruits. Sci. Hortic. 2014, 175, 111–120. [Google Scholar] [CrossRef]
  67. Dangles, O.; Fenger, J.-A. The chemical reactivity of anthocyanins and its consequences in food science and nutrition. Molecules 2018, 23, 1970. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  68. Speer, H.; D’Cunha, N.M.; Alexopoulos, N.I.; McKune, A.J.; Naumovski, N. Anthocyanins and human health—A focus on oxidative stress, inflammation and disease. Antioxidants 2020, 9, 366. [Google Scholar] [CrossRef] [PubMed]
  69. Lin, B.W.; Gong, C.-C.; Song, H.-F.; Cui, Y.-Y. Effects of anthocyanins on the prevention and treatment of cancer. Br. J. Pharm. 2017, 174, 1226–1243. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  70. Zhao, C.; Giusti, M.M.; Malik, M.; Moyer, M.P.; Magnuson, B.A. Effects of commercial anthocyanin-rich extracts on colonic cancer and non-tumorigenic colon cell growth. J. Agric. Food Chem. 2004, 52, 6122–6128. [Google Scholar] [CrossRef]
  71. Zhang, Y.; Vareed, S.K.; Nair, M.G. Human tumor cell growth inhibition by nontoxic anthocyanidins, the pigments in fruits and vegetables. Life Sci. 2005, 76, 1465–1472. [Google Scholar] [CrossRef]
  72. Lila, M.A. Anthocyanins and human health: An in vitro investigative approach. J. Biomed. Biotechnol. 2004, 5, 306–313. [Google Scholar] [CrossRef]
  73. Ghosh, D.; Konishi, T. Anthocyanins and anthocyanin-rich extracts: Role in diabetes and eye function. Asia Pac. J. Clin. Nutr. 2007, 16, 200–208. [Google Scholar]
  74. Nomi, Y.; Iwasaki-Kurashige, K.; Matsumoto, H. therapeutic effects of anthocyanins for vision and eye health. Molecules 2019, 24, 3311. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  75. Kunchithapautham, K.; Rohrer, B. Apoptosis and autophagy in photoreceptors exposed to oxidative stress. Autophagy 2007, 3, 433–441. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  76. Tao, Y.; Chen, T.; Yang, G.-Q.; Peng, G.-H.; Yan, Z.-J.; Huang, Y.-F. Anthocyanin can arrest the cone photoreceptor degeneration and act as a novel treatment for retinitis pigmentosa. Int. J. Ophthalmol. 2016, 9, 153–158. [Google Scholar] [PubMed]
  77. Liu, Y.; Song, X.; Han, Y.; Zhou, F.; Zhang, D.; Ji, B.; Hu, J.; Lv, Y.; Cai, S.; Wei, Y.; et al. Identification of anthocyanin components of wild Chinese blueberries and amelioration of light-induced retinal damage in pigmented rabbit using whole berries. J. Agric. Food Chem. 2011, 59, 356–363. [Google Scholar] [CrossRef]
  78. Tanaka, J.; Kadekaru, T.; Ogawa, K.; Hitoe, S.; Shimoda, H.; Hara, H. Maqui berry (Aristotelia chilensis) and the constituent delphinidin glycoside inhibit photoreceptor cell death induced by visible light. Food Chem. 2013, 139, 129–137. [Google Scholar] [CrossRef]
  79. Chen, L.; Deng, H.; Cui, H.; Fang, J.; Zuo, Z.; Deng, J.; Li, Y.; Wang, X.; Zhao, L. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 2017, 9, 7204–7218. [Google Scholar] [CrossRef] [Green Version]
  80. Coussens, L.; Werb, Z. Inflammation and cancer. Nature 2002, 420, 860–867. [Google Scholar] [CrossRef]
  81. Gomes, A.; Fernandes, E.; Lima, J.L.F.C.; Mira, L.; Corvo, M.L. Molecular mechanisms of anti-inflammatory activity mediated by flavonoids. Curr. Med. Chem. 2008, 15, 1586–1605. [Google Scholar] [CrossRef]
  82. Seeram, N.P.; Momin, R.A.; Nair, M.G.; Bourquin, L.D. Cyclooxygenase inhibitory and antioxidant cyanidin glycosides in cherries and berries. Phytomedicine 2001, 8, 362–369. [Google Scholar] [CrossRef]
  83. Bignotto, L.; Rocha, J.; Sepodes, B.; Eduardo-Figueira, M.; Pinto, R.; Chaud, M.; de Carvalho, J.; Moreno, H., Jr.; Mota-Filipeet, H. Anti-inflammatory effect of lycopene on carrageenan-induced paw oedema and hepatic ischaemia-reperfusion in the rat. Br. J. Nutr. 2009, 102, 126–133. [Google Scholar] [CrossRef] [Green Version]
  84. Lu, T.-C.; Ko, Y.-Z.; Huang, H.-W.; Hung, Y.-C.; Lin, Y.-C.; Peng, W.-H. Analgesic and anti-inflammatory activities of aqueous extract from Glycine tomentella root in mice. J. Ethnopharmacol. 2007, 113, 142–148. [Google Scholar] [CrossRef] [PubMed]
  85. Hsieh, H.-L.; Yang, C.-M. Role of redox signaling in neuroinflammation and neurodegenerative diseases. Biomed Res. Int. 2013, 484613. [Google Scholar] [CrossRef]
  86. Scarano, A.; Butelli, E.; De Santis, S.; Cavalcanti, E.; Hill, L.; De Angelis, M.; Giovinazzo, G.; Chieppa, M.; Martin, C.; Santino, A. Combined dietary anthocyanins, flavonols, and stilbenoids alleviate inflammatory bowel disease symptoms in mice. Front. Nutr. 2018, 4, 75. [Google Scholar] [CrossRef] [Green Version]
  87. Liso, M.; De Santis, S.; Scarano, A.; Verna, G.; Dicarlo, M.; Galleggiante, V.; Campiglia, P.; Mastronardi, M.; Lippolis, A.; Vacca, M.; et al. Bronze-tomato enriched diet affects the intestinal microbiome under homeostatic and inflammatory conditions. Nutrients 2018, 10, 1862. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  88. Tomlinson, M.L.; Butelli, E.; Martin, C.; Carding, S.R. Flavonoids from engineered tomatoes inhibit gut barrier pro-inflammatory cytokines and chemokines, via SAPK/JNK and p38 MAPK pathways. Front. Nutr. 2017, 4, 61. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  89. Mann, E.R.; Li, X. Intestinal antigen-presenting cells in mucosal immune homeostasis: Crosstalk between dendritic cells, macrophages and B-cells. World J. Gastroenterol. 2014, 20, 9653–9664. [Google Scholar] [CrossRef] [PubMed]
  90. Kmieć, Z.; Cyman, M.; Ślebioda, T.J. Cells of the innate and adaptive immunity and their interactions in inflammatory bowel disease. Adv. Med. Sci. 2017, 62, 1–16. [Google Scholar] [CrossRef]
  91. Roy, P.K.; Rashid, F.; Bragg, J.; Ibdah, J.A. Role of the JNK signal transduction pathway in inflammatory bowel disease. World J. Gastroenterol. 2008, 14, 200–202. [Google Scholar] [CrossRef]
  92. Feng, Y.J.; Li, Y.Y. The role of p38 mitogen-activated protein kinase in the pathogenesis of inflammatory bowel disease. J. Dig. Dis. 2011, 12, 327–332. [Google Scholar] [CrossRef]
  93. Arthur, J.S.C.; Ley, S.C. Mitogen-activated protein kinases in innate immunity. Nat. Rev. Immunol. 2013, 13, 679–692. [Google Scholar] [CrossRef]
  94. Cassidy, A.; O’Reilly, E.J.; Kay, C.; Sampson, L.; Franz, M.; Forman, J.P.; Curhan, G.; Rimm, E.B. Habitual intake of flavonoid subclasses and incident hypertension in adults. Am. J. Clin. Nutr. 2011, 93, 338–347. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  95. Erlund, I.; Koli, R.; Alfthan, G.; Marniemi, J.; Puukka, P.; Mustonen, P.; Mattila, P.; Jula, A. Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol. Am. J. Clin. Nutr. 2008, 87, 323–331. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  96. Miyazaki, K.; Makino, K.; Iwadate, E.; Deguchi, Y.; Ishikawa, F. Anthocyanins from purple sweet potato Ipomoea batatas cultivar Ayamurasaki suppress the development of atherosclerotic lesions and both enhancements of oxidative stress and soluble vascular cell adhesion molecule-1 in apolipoprotein E-Deficient Mice. J. Agric. Food Chem. 2008, 56, 11485–11492. [Google Scholar] [CrossRef]
  97. Rodriguez-Mateos, A.; Rendeiro, C.; Bergillos-Meca, T.; Tabatabaee, S.; George, T.W.; Heiss, C.; Spencer, J.P.E. Intake and time dependence of blueberry flavonoid-induced improvements in vascular function: A randomized, controlled, double-blind, crossover intervention study with mechanistic insights into biological activity. Am. J. Clin. Nutr. 2013, 98, 1179–1191. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  98. Tsuda, T.; Shiga, K.; Ohshima, K.; Kawakishi, S.; Osawa, T. Inhibition of Lipid Peroxidation and the Active Oxygen Radical Scavenging Effect of Anthocyanin Pigments Isolated from Phaseolus vulgaris L. Biochem. Pharm. 1996, 52, 1033–1039. [Google Scholar] [CrossRef]
  99. Libby, P.; Ridker, P.M.; Hansson, G.K. Progress and challenges in translating the biology of atherosclerosis. Nature 2011, 473, 317–325. [Google Scholar] [CrossRef]
  100. Krga, I.; Milenkovic, M. Anthocyanins: From sources and bioavailability to cardiovascular-health benefits and molecular mechanisms of action. J. Agric. Food Chem. 2019, 67, 1771–1783. [Google Scholar] [CrossRef] [PubMed]
  101. Osterud, B.; Bjorklid, E. Role of monocytes in atherogenesis. Physiol. Rev. 2003, 83, 1069–1112. [Google Scholar] [CrossRef] [Green Version]
Antioxidants 09 01017 g001 550
Figure 1. General anthocyanin structure and list of the most common anthocyanins found in nature (from [5]) (A). Examples of purple tomato fruits obtained by breeding: Aft/Aft · atv/atv · hp2/hp2 in MicroTom background (on the left); Aft/Aft · atv/atv in Ailsa Craig background (B). Structure of petunidin-3-(trans-p-coumaroyl)-rutinoside-5-glucoside, one of the most abundant anthocyanin molecules identified in purple tomato fruits (C). Redrawn from [6].
Figure 1. General anthocyanin structure and list of the most common anthocyanins found in nature (from [5]) (A). Examples of purple tomato fruits obtained by breeding: Aft/Aft · atv/atv · hp2/hp2 in MicroTom background (on the left); Aft/Aft · atv/atv in Ailsa Craig background (B). Structure of petunidin-3-(trans-p-coumaroyl)-rutinoside-5-glucoside, one of the most abundant anthocyanin molecules identified in purple tomato fruits (C). Redrawn from [6].
Antioxidants 09 01017 g001
Antioxidants 09 01017 g002 550
Figure 2. Schematic representation of the main positive effects exerted by anthocyanins as anti-inflammatory compounds. Abbreviations: ROS, reactive oxygen species; RNS, reactive nitrogen species; COX, cyclooxygenase enzyme. Adapted from [85].
Figure 2. Schematic representation of the main positive effects exerted by anthocyanins as anti-inflammatory compounds. Abbreviations: ROS, reactive oxygen species; RNS, reactive nitrogen species; COX, cyclooxygenase enzyme. Adapted from [85].
Antioxidants 09 01017 g002
Antioxidants 09 01017 g003 550
Figure 3. Overview of the positive effects carried out by anthocyanins from purple tomato lines as health beneficial molecules. Results from in vitro and in vivo studies published in recent years: 1 [60]; 2 [52]; 3 [62]; 4 [64]; 5 [86]; 6 [87]; 7 [88]; 8 [10].
Figure 3. Overview of the positive effects carried out by anthocyanins from purple tomato lines as health beneficial molecules. Results from in vitro and in vivo studies published in recent years: 1 [60]; 2 [52]; 3 [62]; 4 [64]; 5 [86]; 6 [87]; 7 [88]; 8 [10].
Antioxidants 09 01017 g003
Table
Table 1. Content of the main carotenoids and polyphenols found in tomato ripe fruits from different cultivated varieties [44]. Values are expressed as mg bioactive compound 100 g−1 fresh weight (FW).
Table 1. Content of the main carotenoids and polyphenols found in tomato ripe fruits from different cultivated varieties [44]. Values are expressed as mg bioactive compound 100 g−1 fresh weight (FW).
CarotenoidCarotenoid ConcentrationPolyphenolPolyphenol Concentration
Lycopene7.8–18.1Naringenin chalcone0.9–18.2
Phytoene1.0–2.9Rutin (quercetin-3-O-rutinoside)0.5–4.5
Phytofluene0.2–1.6Quercetin0.7–4.4
β-Carotene0.1–1.2Chlorogenic acid1.4–3.3
γ-Carotene0.05–0.3Caffeic acid0.1–1.3
δ-Carotene0–0.2Naringenin0–1.3
Lutein0.09Kaempferol-3-O-rutinoside0–0.8
Neurosporene0–0.03p-Coumaric acid0–0.6
α-Carotene0–0.002Ferulic acid0.2–0.5
Neoxanthin-Kaempferol0–0.2
Violaxanthin-Myricetin-
Cyanidin-
Pelargonidin-
Delphinidin-
Table
Table 2. Main purple tomato lines obtained through genetic engineering or breeding programs and relative anthocyanin content and composition. Abbreviations: Del, delphinidin; Pet, petunidin; Mal, malvidin; Cya, cyanidin; Peo, peonidin; rut, rutinoside; glc, glucoside; glyc, glycoside; hex, hexoside; FW, fresh weight.
Table 2. Main purple tomato lines obtained through genetic engineering or breeding programs and relative anthocyanin content and composition. Abbreviations: Del, delphinidin; Pet, petunidin; Mal, malvidin; Cya, cyanidin; Peo, peonidin; rut, rutinoside; glc, glucoside; glyc, glycoside; hex, hexoside; FW, fresh weight.
Tomato LineOriginMain Anthocyanins DetectedAnthocyanin Concentration in FruitRef.
Del/Ros1Genetic engineeringPet-3-(trans-p-coumaroyl)-rut-5-glc;
Del-3-(trans-p-coumaroyl)-rut-5-glc;
Pet-3-(feruloyl)-rut-5-glc;
Del-3-(feruloyl)-rut-5-glc		2.835 ± 0.456 mg g−1 FW[52]
Del/Ros1Genetic engineeringDel-3-(trans-p-coumaroyl)-rut-5-glc;
Pet-3-(trans-p-coumaroyl)-rut-5-glc;
Mal-3-(p-coumaroyl)-rut-5-glc;
Mal-3-(feruloyl)-rut-5-glc		peel: 5.1 ± 0.5 g kg−1 DW
flesh: 5.8 ± 0.3 g kg−1 DW
whole fruit: 5.2 ± 0.5 g Peo-3-glc equivalent kg−1 DW, or 0.5% of DW		[54]
Del/Ros1 x AtMYB12Genetic engineeringDel-3-(trans-p-coumaroyl)-rut-5-glc;
Pet-3-(trans-p-coumaroyl)-rut-5-glc;
Pet-3-(feruloyl)-rut-5-glc;
Mal-3-(p-coumaroyl)-rut-5-glc		1.154 ± 0.011 mg g−1 FW
2.857 ± 0.218 mg g−1 FW
0.922 ± 0.102 mg g−1 FW
0.598 ± 0.011 mg g−1 FW		[55]
Aft/Aft · atv/atvBreedingPet-3-(p-coumaroyl)-rut-5-glc;
Del-3-rut		peel: 116.11 mg 100 g−1 FW[58]
Sun Black (Aft/Aft · atv/atv)BreedingPet-3-(trans-p-coumaroyl)-rut-5-glc;
Mal-3-(trans-p-coumaroyl)-rut-5-glc		more than 1 mg g−1 DW[6,60]
V118BreedingPet-3-(p-coumaryl)-rut-5-glc;
Pet-3-caffeoyl-rut-5-glc;
Mal-3(p-coumaryl)-rut-5-glc		50.18 mg 100 g−1 DW
9.04 mg 100 g−1 DW
13.09 mg 100 g−1 DW		[61]
Blue Japan Indigo tomato (Aft/Aft · atv/atv)BreedingPet + p-coumaroyl + rut + glyc;
Mal + p-coumaroyl + rut;
Del		peel: 17 mg g−1 DW
pulp: 0.1 mg g−1 DW		[62]
Aft/Aft · atv/atv · hp2/hp2BreedingPet-(p-coumaroyl)-rut-hex
Delphinidin-3-(p-coumaroyl)-rut-glyc
Pet-(p-coumaroyl)-rut-hex
Pet-3-(cafeoyl)-rut-5-glyc
Mal-3-(p-coumaroyl)-rut-5-glyc
Cya-3-O-rut		peel: 90.91 mg 100 g−1 FW[63]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Gonzali, S.; Perata, P. Anthocyanins from Purple Tomatoes as Novel Antioxidants to Promote Human Health. Antioxidants 2020, 9, 1017. https://doi.org/10.3390/antiox9101017

AMA Style

Gonzali S, Perata P. Anthocyanins from Purple Tomatoes as Novel Antioxidants to Promote Human Health. Antioxidants. 2020; 9(10):1017. https://doi.org/10.3390/antiox9101017

Chicago/Turabian Style

Gonzali, Silvia, and Pierdomenico Perata. 2020. "Anthocyanins from Purple Tomatoes as Novel Antioxidants to Promote Human Health" Antioxidants 9, no. 10: 1017. https://doi.org/10.3390/antiox9101017

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop